Evidence map›Paper›PMID 22438548›Full record

ArticleJournal of virology2012

The double-stranded RNA bluetongue virus induces type I interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathway.

Suzana Ruscanu, Florentina Pascale, Mickael Bourge, Behzad Hemati, Jamila Elhmouzi-Younes, Céline Urien, Michel Bonneau, Haru Takamatsu, Jayne Hope, Peter Mertens and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Comprehensive immune profiling reveals thatFrontiers in immunology · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Activation of TLR3/interferon signaling pathway by bluetongue virus results in HIV inhibition in macrophages.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 2 countries.

Suzana RuscanuVirologie et Immunologie Moléculaires, UR892 INRA, Jouy-en-Josas, France.
Florentina Pascale
Mickael Bourge
Behzad Hemati
Jamila Elhmouzi-Younes
Céline Urien
Michel Bonneau
Haru Takamatsu
Jayne Hope
Peter Mertens
Gilles Meyer
Meredith Stewart
Polly Roy
Eliane F Meurs
Stéphanie Dabo
Stéphan Zientara
Emmanuel Breard
Corinne Sailleau
Emilie Chauveau
Damien Vitour
Bernard Charley
Isabelle Schwartz-Cornil
Virologie et Immunologie Moléculaires · FRAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FRInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRInstitut Pasteur · FRLondon School of Hygiene & Tropical Medicine · GBThe Pirbright Institute · GBCentre National de la Recherche Scientifique · FRDépartement Génétique Animale · FRNeuroDiderot · FRRoslin Institute · GBUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

Biotechnology and Biological Sciences Research Council BB/F00852X/1Biotechnology and Biological Sciences Research Council BBS/E/I/00001441Biotechnology and Biological Sciences Research Council BBS/E/I/00001709
6 · The paper itself

Abstract

Dendritic cells (DCs), especially plasmacytoid DCs (pDCs), produce large amounts of alpha/beta interferon (IFN-α/β) upon infection with DNA or RNA viruses, which has impacts on the physiopathology of the viral infections and on the quality of the adaptive immunity. However, little is known about the IFN-α/β production by DCs during infections by double-stranded RNA (dsRNA) viruses. We present here novel information about the production of IFN-α/β induced by bluetongue virus (BTV), a vector-borne dsRNA Orbivirus of ruminants, in sheep primary DCs. We found that BTV induced IFN-α/β in skin lymph and in blood in vivo. Although BTV replicated in a substantial fraction of the conventional DCs (cDCs) and pDCs in vitro, only pDCs responded to BTV by producing a significant amount of IFN-α/β. BTV replication in pDCs was not mandatory for IFN-α/β production since it was still induced by UV-inactivated BTV (UV-BTV). Other inflammatory cytokines, including tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and IL-12p40, were also induced by UV-BTV in primary pDCs. The induction of IFN-α/β required endo-/lysosomal acidification and maturation. However, despite being an RNA virus, UV-BTV did not signal through Toll-like receptor 7 (TLR7) for IFN-α/β induction. In contrast, pathways involving the MyD88 adaptor and kinases dsRNA-activated protein kinase (PKR) and stress-activated protein kinase (SAPK)/Jun N-terminal protein kinase (JNK) were implicated. This work highlights the importance of pDCs for the production of innate immunity cytokines induced by a dsRNA virus, and it shows that a dsRNA virus can induce IFN-α/β in pDCs via a novel TLR-independent and Myd88-dependent pathway. These findings have implications for the design of efficient vaccines against dsRNA viruses.

Indexed as

AnimalsBluetongueBluetongue virusCells, CulturedCytokinesDendritic CellsFemaleImmunity, InnateInterferon Type IMembrane GlycoproteinsMyeloid Differentiation Factor 88Receptors, Interleukin-1SheepSignal TransductionToll-Like Receptor 7Toll-Like Receptor 8CytokinesInterferon Type IMembrane GlycoproteinsMyeloid Differentiation Factor 88Receptors, Interleukin-1TIRAP protein, humanToll-Like Receptor 7Toll-Like Receptor 8

Identifiers

PMID22438548
PMCPMC3347300
OpenAlexW2001022136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.